Daniel M Bloomfield
Overview
Explore the profile of Daniel M Bloomfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu C, Hutt E, Bloomfield D, Gailani D, Weitz J
J Am Coll Cardiol
. 2021 Aug;
78(6):625-631.
PMID: 34353538
Hemostasis and thrombosis are believed to be so intricately linked that any strategies that reduce thrombosis will have an inevitable impact on hemostasis. Consequently, bleeding is viewed as an unavoidable...
2.
Richards D, Aronovitz M, Liu P, Martin G, Tam K, Pande S, et al.
Circ Heart Fail
. 2021 Jan;
14(1):e007300.
PMID: 33464954
Background: Augmentation of NP (natriuretic peptide) receptor and cyclic guanosine monophosphate (cGMP) signaling has emerged as a therapeutic strategy in heart failure (HF). cGMP-specific PDE9 (phosphodiesterase 9) inhibition increases cGMP...
3.
Beldhuis I, Streng K, van der Meer P, Ter Maaten J, OConnor C, Metra M, et al.
J Card Fail
. 2019 Jul;
25(11):866-874.
PMID: 31319165
Background: Changes in renal function have been associated with differential outcomes in patients with acute heart failure (HF). However, individual trajectories of changes in renal function are unknown, and it...
4.
Metra M, Cotter G, Senger S, Edwards C, Cleland J, Ponikowski P, et al.
Circ Heart Fail
. 2018 May;
11(5):e004644.
PMID: 29748350
Background: The importance of a serum creatinine increase, traditionally considered worsening renal function (WRF), during admission for acute heart failure has been recently debated, with data suggesting an interaction between...
5.
Rubio-Gracia J, Demissei B, Ter Maaten J, Cleland J, OConnor C, Metra M, et al.
Int J Cardiol
. 2018 Mar;
258:185-191.
PMID: 29544928
Background: Congestion is the main reason for hospital admission for acute decompensated heart failure (ADHF). A better understanding of the clinical course of congestion and factors associated with decongestion are...
6.
Damman K, Valente M, Van Veldhuisen D, Cleland J, OConnor C, Metra M, et al.
Int J Mol Sci
. 2017 Jul;
18(7).
PMID: 28698481
The aim of this study was to evaluate the ability of Neutrophil Gelatinase-Associated Lipocalin (NGAL) to predict clinically relevant worsening renal function (WRF) in acute heart failure (AHF). Plasma NGAL...
7.
Liu L, Valente M, Postmus D, OConnor C, Metra M, Dittrich H, et al.
Cardiovasc Drugs Ther
. 2017 Jun;
31(3):281-293.
PMID: 28656542
Background: Over the last 50 years, clinical trials of novel interventions for acute heart failure (AHF) have, with few exceptions, been neutral or shown harm. We hypothesize that this might...
8.
Sharma A, Demissei B, Tromp J, Hillege H, Cleland J, OConnor C, et al.
Eur J Heart Fail
. 2017 Jun;
19(10):1310-1320.
PMID: 28639369
Aims: It is unclear whether distinct pathophysiological processes are present among patients with acute heart failure (AHF), with and without diabetes. Network analysis of biomarkers may identify correlative associations that...
9.
Tromp J, Khan M, Mentz R, OConnor C, Metra M, Dittrich H, et al.
JACC Heart Fail
. 2017 Jun;
5(7):507-517.
PMID: 28624483
Objectives: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with...
10.
Cowie M, Filippatos G, Alonso Garcia M, Anker S, Baczynska A, Bloomfield D, et al.
Eur J Heart Fail
. 2017 Mar;
19(6):718-727.
PMID: 28345190
Despite the availability of a number of different classes of therapeutic agents with proven efficacy in heart failure, the clinical course of heart failure patients is characterized by a reduction...